Product information

Edronax 4 mg
60
reboxetine
1374032
8.74 / 10
Locked

Product properties

71620-89-8
N06AX18
Pfizer
Tablet
€20.39
BE190251
05415062305546
M1
Public
190251-04

Pharmacist Assessment

Discontinued product — remaining stock available

The commercialization of this product has been stopped (reason: Commercial reasons), but remaining stock is available at wholesalers (score 8.74/10). This stock will not be replenished. Plan the switch to an alternative.

No available alternative found in the system. Consult the physician for a therapeutic alternative.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 17 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Available alternatives

Status history (PharmaStatus)

Commercialization stopped Active
- present

Commercial reasons

Alternative available
Available
Until 30/08/2026

Composition

1 ingredient

Substance Type Strength CAS
Active ingredient
5.22 mg

Additional information

Availability statistics

Commercialization stopped
22 days
4
0
31/08/2026